Healthcare Invistments
Fawaz Alhokair’s healthcare portfolio was shaped by both strategic conviction and personal experience — a recognition that Saudi Arabia’s healthcare system had critical gaps that represented both a social obligation and a long-term investment opportunity. Across five carefully selected ventures covering long-term care, diagnostics, telehealth, skincare, and reproductive medicine, the Group is bringing proven international models into the Saudi market and helping build the healthcare infrastructure that the Kingdom’s growing population will increasingly depend upon. Each investment targets a distinct and underserved segment, collectively advancing the Kingdom’s Vision 2030 healthcare transformation agenda.
SAR1.4B
SAR 1.4B projected annual revenue
1,900+
Beds capacity planned
9
Long-term care locations targeted
5
Healthcare ventures
Top brands
Biolab Medical Laboratories
Biolab is a group of medical diagnostic laboratories with over two decades of operational history, founded in 2001 with a mission to deliver patient-centred care through the latest advances in diagnostic technology. The Biolab model — built around what it calls the ‘New Lab Experience’ — prioritises accuracy, speed, and accessibility across its network of facilities. The Fawaz Alhokair Group’s joint venture with Biolab is a strategic move to bring premium diagnostic services into closer proximity to the Group’s real estate and healthcare ecosystem, serving both individual patients and institutional healthcare providers. As demand for high-quality, affordable diagnostic services continues to grow across the Kingdom, the Biolab partnership positions the Group to benefit from long-term structural tailwinds in Saudi Arabia’s healthcare transformation agenda.
TruDoc 24×7
TruDoc 24×7 is a leading 24-hour, 7-day telehealth and care management platform built around five fully integrated healthcare entry points: a mobile application for patients on the move, on-site virtual clinics for workplace settings, a hospitalist programme for in-hospital patients, a hospital-at-home programme with continuous telemonitoring, and a hospital-based urgent care centre — all connected to a centralised 24×7 Telemedicine Control Centre. This multi-channel architecture enables TruDoc to serve patients across the full continuum of care — from prevention and acute treatment through to chronic disease management — eliminating the barriers of geography, time, and cost that have historically limited healthcare access. At a time when Saudi Arabia is actively investing in digital health infrastructure as a cornerstone of its Vision 2030 healthcare transformation, TruDoc’s model is both timely and transformative.
Skin Laundry
Skin Laundry is a globally recognised premium skincare brand founded in 2013, built on the belief that professional-grade skincare treatments should be fast, accessible, and results-driven. With 40+ locations across three continents — spanning the United States, United Kingdom, Hong Kong, and the Middle East — Skin Laundry has grown into both a clinic operator and a branded skincare product line. The brand made its GCC debut in Dubai Marina in 2020, and the joint venture with Fawaz Alhokair Group brings Skin Laundry’s signature treatments and products to the Kingdom of Saudi Arabia, where demand for aesthetic and preventative skincare is growing rapidly among both male and female consumers. The partnership reflects the Group’s broader strategy of importing proven international consumer concepts and scaling them within its extensive real estate and retail ecosystem.
IVI-RMA — Fertility Clinics
IVI-RMA Global is the world’s foremost fertility group, recognised internationally for its leadership in research, clinical success rates, and patient care across reproductive medicine. With 75 clinical offices and 28 specialised laboratories operating in 9 countries, the group employs 465+ physicians and embryologists and facilitates the birth of more than 100 babies daily worldwide. IVI-RMA’s global reach and scientific rigour make it an ideal partner for bringing world-class IVF and reproductive healthcare to Saudi Arabia, where evolving social norms and increasing awareness are driving demand for fertility services. The joint venture with Fawaz Alhokair Group represents a landmark commitment to expanding access to specialist reproductive medicine in the Kingdom, combining IVI-RMA’s clinical excellence with the Group’s deep understanding of the Saudi consumer and its real estate infrastructure.
